HALO logo

Halozyme Therapeutics (HALO) Interest expense

annual interest expense:

$18.09M-$667.00K(-3.56%)
December 31, 2024

Summary

  • As of today (June 22, 2025), HALO annual interest expense is $18.09 million, with the most recent change of -$667.00 thousand (-3.56%) on December 31, 2024.
  • During the last 3 years, HALO annual interest expense has risen by +$10.57 million (+140.43%).
  • HALO annual interest expense is now -17.69% below its all-time high of $21.98 million, reached on December 31, 2017.

Performance

HALO Interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOincome statement metrics

quarterly interest expense:

$4.53M-$15.00K(-0.33%)
March 31, 2025

Summary

  • As of today (June 22, 2025), HALO quarterly interest expense is $4.53 million, with the most recent change of -$15.00 thousand (-0.33%) on March 31, 2025.
  • Over the past year, HALO quarterly interest expense has increased by +$18.00 thousand (+0.40%).
  • HALO quarterly interest expense is now -39.78% below its all-time high of $7.51 million, reached on September 30, 2022.

Performance

HALO quarterly interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOincome statement metrics

TTM interest expense:

$18.11M+$18.00K(+0.10%)
March 31, 2025

Summary

  • As of today (June 22, 2025), HALO TTM interest expense is $18.11 million, with the most recent change of +$18.00 thousand (+0.10%) on March 31, 2025.
  • Over the past year, HALO TTM interest expense has dropped by -$613.00 thousand (-3.27%).
  • HALO TTM interest expense is now -18.13% below its all-time high of $22.13 million, reached on September 30, 2017.

Performance

HALO TTM interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOincome statement metrics

Interest expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

HALO Interest expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-3.6%+0.4%-3.3%
3 y3 years+140.4%+157.3%+147.4%
5 y5 years+55.6%-15.4%+31.5%

HALO Interest expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-3.6%+140.4%-39.8%+157.3%-14.2%+147.4%
5 y5-year-11.2%+140.4%-39.8%+158.3%-14.2%+147.4%
alltimeall time-17.7%>+9999.0%-39.8%>+9999.0%-18.1%>+9999.0%

HALO Interest expense History

DateAnnualQuarterlyTTM
Mar 2025
-
$4.53M(-0.3%)
$18.11M(+0.1%)
Dec 2024
$18.09M(-3.6%)
$4.54M(+0.4%)
$18.09M(-3.6%)
Sep 2024
-
$4.52M(0.0%)
$18.77M(+0.1%)
Jun 2024
-
$4.52M(+0.4%)
$18.76M(+0.2%)
Mar 2024
-
$4.51M(-13.7%)
$18.73M(-0.2%)
Dec 2023
$18.76M(+10.7%)
$5.22M(+15.9%)
$18.76M(+3.6%)
Sep 2023
-
$4.50M(+0.2%)
$18.11M(-14.2%)
Jun 2023
-
$4.49M(-1.1%)
$21.12M(+7.0%)
Mar 2023
-
$4.54M(-0.6%)
$19.73M(+16.4%)
Dec 2022
$16.95M(+125.2%)
$4.57M(-39.2%)
$16.95M(+17.4%)
Sep 2022
-
$7.51M(+142.1%)
$14.43M(+66.4%)
Jun 2022
-
$3.10M(+76.5%)
$8.67M(+18.5%)
Mar 2022
-
$1.76M(-14.4%)
$7.32M(-2.7%)
Dec 2021
$7.53M(-63.1%)
$2.06M(+17.2%)
$7.53M(-28.4%)
Sep 2021
-
$1.75M(+0.1%)
$10.51M(-23.5%)
Jun 2021
-
$1.75M(-10.8%)
$13.74M(-19.1%)
Mar 2021
-
$1.97M(-61.0%)
$17.00M(-16.6%)
Dec 2020
$20.38M(+75.3%)
$5.04M(+0.9%)
$20.38M(+6.8%)
Sep 2020
-
$4.99M(-0.3%)
$19.07M(+18.0%)
Jun 2020
-
$5.00M(-6.4%)
$16.16M(+17.4%)
Mar 2020
-
$5.35M(+43.3%)
$13.77M(+18.4%)
Dec 2019
$11.63M(-35.6%)
$3.73M(+79.5%)
$11.63M(-0.2%)
Sep 2019
-
$2.08M(-20.5%)
$11.65M(-15.9%)
Jun 2019
-
$2.61M(-18.5%)
$13.86M(-13.5%)
Mar 2019
-
$3.21M(-14.6%)
$16.02M(-11.2%)
Dec 2018
$18.04M
$3.75M(-12.4%)
$18.04M(-8.6%)
Sep 2018
-
$4.29M(-10.1%)
$19.74M(-6.0%)
DateAnnualQuarterlyTTM
Jun 2018
-
$4.77M(-8.8%)
$21.00M(-3.5%)
Mar 2018
-
$5.23M(-4.2%)
$21.77M(-1.0%)
Dec 2017
$21.98M(+10.0%)
$5.46M(-1.4%)
$21.98M(-0.6%)
Sep 2017
-
$5.54M(-0.0%)
$22.13M(+1.3%)
Jun 2017
-
$5.54M(+1.7%)
$21.84M(+1.4%)
Mar 2017
-
$5.45M(-2.7%)
$21.55M(+7.9%)
Dec 2016
$19.98M(+284.1%)
$5.60M(+6.6%)
$19.98M(+27.4%)
Sep 2016
-
$5.25M(+0.1%)
$15.68M(+33.7%)
Jun 2016
-
$5.25M(+35.4%)
$11.73M(+50.8%)
Mar 2016
-
$3.88M(+197.7%)
$7.78M(+49.5%)
Dec 2015
$5.20M(-6.8%)
$1.30M(+0.1%)
$5.20M(-1.4%)
Sep 2015
-
$1.30M(+0.2%)
$5.28M(-1.4%)
Jun 2015
-
$1.30M(0.0%)
$5.35M(-2.8%)
Mar 2015
-
$1.30M(-5.7%)
$5.50M(-1.4%)
Dec 2014
$5.58M(+70.5%)
$1.38M(+0.1%)
$5.58M(+13.2%)
Sep 2014
-
$1.38M(-5.2%)
$4.93M(+11.9%)
Jun 2014
-
$1.45M(+5.5%)
$4.40M(+15.8%)
Mar 2014
-
$1.38M(+89.3%)
$3.80M(+16.1%)
Dec 2013
$3.27M(>+9900.0%)
$727.00K(-14.5%)
$3.27M(+28.5%)
Sep 2013
-
$850.00K(+0.1%)
$2.55M(+50.1%)
Jun 2013
-
$849.00K(+0.1%)
$1.70M(+100.1%)
Mar 2013
-
$848.00K(>+9900.0%)
$848.00K(>+9900.0%)
Dec 2012
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2012
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2012
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2012
-
$0.00
$0.00
Dec 2011
$0.00
-
-

FAQ

  • What is Halozyme Therapeutics annual interest expense?
  • What is the all time high annual interest expense for Halozyme Therapeutics?
  • What is Halozyme Therapeutics annual interest expense year-on-year change?
  • What is Halozyme Therapeutics quarterly interest expense?
  • What is the all time high quarterly interest expense for Halozyme Therapeutics?
  • What is Halozyme Therapeutics quarterly interest expense year-on-year change?
  • What is Halozyme Therapeutics TTM interest expense?
  • What is the all time high TTM interest expense for Halozyme Therapeutics?
  • What is Halozyme Therapeutics TTM interest expense year-on-year change?

What is Halozyme Therapeutics annual interest expense?

The current annual interest expense of HALO is $18.09M

What is the all time high annual interest expense for Halozyme Therapeutics?

Halozyme Therapeutics all-time high annual interest expense is $21.98M

What is Halozyme Therapeutics annual interest expense year-on-year change?

Over the past year, HALO annual interest expense has changed by -$667.00K (-3.56%)

What is Halozyme Therapeutics quarterly interest expense?

The current quarterly interest expense of HALO is $4.53M

What is the all time high quarterly interest expense for Halozyme Therapeutics?

Halozyme Therapeutics all-time high quarterly interest expense is $7.51M

What is Halozyme Therapeutics quarterly interest expense year-on-year change?

Over the past year, HALO quarterly interest expense has changed by +$18.00K (+0.40%)

What is Halozyme Therapeutics TTM interest expense?

The current TTM interest expense of HALO is $18.11M

What is the all time high TTM interest expense for Halozyme Therapeutics?

Halozyme Therapeutics all-time high TTM interest expense is $22.13M

What is Halozyme Therapeutics TTM interest expense year-on-year change?

Over the past year, HALO TTM interest expense has changed by -$613.00K (-3.27%)
On this page